Racial and ethnic disparities in metabolic dysfunction- associated steatotic liver disease outcomes: A call for culturally sensitive interventions: Editorial on "Differences in liver and mortality outcomes of nonalcoholic fatty liver disease by race and ethnicity: A longitudinal real-world study"

被引：3
|
作者：
Bae, Jae Hyun [1 ]
机构：
[1] Seoul Natl Univ Hosp, Dept Internal Med, 101,Daehak Ro, Seoul 03080, South Korea
来源：
CLINICAL AND MOLECULAR HEPATOLOGY | 2024年 / 30卷 / 04期
关键词：
Ethnicity; Healthcare disparities; Non-alcoholic fatty liver disease; Racial groups; Social determinants of health; SUSCEPTIBILITY; PREVALENCE; SEVERITY; PNPLA3;
D O I：
10.3350/cmh.2024.0562
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [21] Disease Progression for Histologic Diagnosis of Metabolic Dysfunction-Associated Steatotic Liver Disease in the Real-World: A Nationwide US Study
    Zhang, Xinrong
    Kam, Leslie Yeeman
    Barnett, Scott D.
    Henry, Linda
    Cheung, Ramsey
    Nguyen, Mindie H.
    DIGESTIVE DISEASES, 2024,
  • [22] The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease
    Hardy, Timothy
    Wonders, Kristy
    Younes, Ramy
    Aithal, Guruprasad P.
    Aller, Rocio
    Allison, Michael
    Bedossa, Pierre
    Betsou, Fay
    Boursier, Jerome
    Brosnan, M. Julia
    Burt, Alastair
    Cobbold, Jeremy
    Cortez-Pinto, Helena
    Day, Chris P.
    Dufour, Jean-Francois
    Ekstedt, Mattias
    Francque, Sven
    Harrison, Stephen
    Miele, Luca
    Nasr, Patrik
    Papatheodoridis, George
    Petta, Salvatore
    Tiniakos, Dina
    Torstenson, Richard
    Valenti, Luca
    Holleboom, Adriaan G.
    Yki-Jarvinen, Hannele
    Geier, Andreas
    Romero-Gomez, Manuel
    Ratziu, Vlad
    Bugianesi, Elisabetta
    Schattenberg, Jorn M.
    Anstee, Quentin M.
    CONTEMPORARY CLINICAL TRIALS, 2020, 98
  • [23] Comparing diabetes prediction based on metabolic dysfunction-associated steatotic liver disease and nonalcoholic fatty liver disease: the ELSA-Brasil study
    Lopes, Gabriela Wuensch
    Canhada, Scheine Leite
    Reis, Rodrigo Citton Padilha dos
    Diniz, Maria de Fatima Haueisen Sander
    Goulart, Alessandra Carvalho
    Faria, Luciana Costa
    Griep, Rosane Harter
    Perazzo, Hugo
    Duncan, Bruce Bartholow
    Schmidt, Maria Ines
    CADERNOS DE SAUDE PUBLICA, 2024, 40 (11):
  • [24] Disparities in Metabolic Dysfunction-Associated Steatotic Liver Disease Prevalence, Diagnosis, Treatment, and Outcomes: A Narrative Review
    Miller, Kaia C.
    Geyer, Bridget
    Alexopoulos, Anastasia-Stefania
    Moylan, Cynthia A.
    Pagidipati, Neha
    DIGESTIVE DISEASES AND SCIENCES, 2025, 70 (01) : 154 - 167
  • [25] Metabolic dysfunction-associated steatotic liver disease: Update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver disease
    Kanwal, Fasiha
    Neuschwander-Tetri, Brent A.
    Loomba, Rohit
    Rinella, Mary E.
    HEPATOLOGY, 2024, 79 (05) : 1212 - 1219
  • [26] Longitudinal Outcomes Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-analysis of 129 Studies
    Chan, Kai En
    Ong, Elden Yen Hng
    Chung, Charlotte Hui
    Ong, Christen En Ya
    Koh, Benjamin
    Tan, Darren Jun Hao
    Lim, Wen Hui
    Yong, Jie Ning
    Xiao, Jieling
    Wong, Zhen Yu
    Syn, Nicholas
    Kaewdech, Apichat
    Teng, Margaret
    Wang, Jiong-Wei
    Chew, Nicholas
    Young, Dan Yock
    Know, Alfred
    Siddiqui, Mohammad Shadab
    Huang, Daniel Q.
    Tamaki, Nobuharu
    Wong, Vincent Wai-Sun
    Mantzoros, Christos S.
    Sanyal, Arun
    Noureddin, Mazen
    Ng, Cheng Han
    Muthiah, Mark
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 22 (03) : 488 - 498
  • [27] Metabolic-associated fatty liver disease is less effective in predicting mortality than non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease: Letter to the editor on "Prognosis of biopsy-confirmed metabolic dysfunction-associated steatotic liver disease: A sub-analysis of the CLIONE study"
    Zhu, Yixuan
    Ma, Xiaoyan
    Ni, Wenjing
    Yeo, Yee Hui
    Shi, Junping
    Li, Jie
    CLINICAL AND MOLECULAR HEPATOLOGY, 2024, 30 (04)
  • [28] Sex and Race-Ethnic Disparities in Metabolic Dysfunction-Associated Steatotic Liver Disease: An Analysis of 40,166 Individuals
    Fu, Clarissa Elysia
    Teng, Margaret
    Tung, Daniel
    Ramadoss, Vijay
    Ong, Christen
    Koh, Benjamin
    Lim, Wen Hui
    Tan, Darren Jun Hao
    Koh, Jia Hong
    Nah, Benjamin
    Syn, Nicholas
    Tamaki, Nobuharu
    Siddiqui, Mohammad Shadab
    Wijarnpreecha, Karn
    Ioannou, George N.
    Nakajima, Atsushi
    Noureddin, Mazen
    Sanyal, Arun J.
    Ng, Cheng Han
    Muthiah, Mark
    DIGESTIVE DISEASES AND SCIENCES, 2024, 69 (09) : 3195 - 3205
  • [29] Gender disparities in metabolic dysfunction associated steatotic liver disease: transcriptomic results from the BARIA longitudinal cohort study
    Koning, M.
    Hanssen, N. M. J.
    Verheij, J.
    Doukas, M.
    van de laar, A.
    Bruin, S.
    Herrema, H.
    Gerdes, V.
    Meijnikman, A. S.
    Nieuwdorp, M.
    DIABETOLOGIA, 2024, 67 : S507 - S507
  • [30] Metabolic-associated steatotic liver disease and risk of Alzheimer's disease: a real-world retrospective cohort study
    Zhang, Jiaqi
    Wang, Wenzhao
    Hou, Xingyun
    Wu, Jia
    Wang, Yifan
    Fan, Jianling
    Zhang, Zhiyu
    Yuan, Zhizhong
    Sun, Cuifen
    Lu, Bin
    Zheng, Jiaoyang
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
12345